Tech Company Financing Transactions
ImmunOs Therapeutics Funding Round
ImmunOs Therapeutics closed a $11 million Series C funding round on 9/17/2024. Backers included BioMed Ventures, Double Point Ventures and GIMV.
Transaction Overview
BioMed Ventures (Lead Investor)
Double Point Ventures (Lead Investor)
GIMV (Lead Investor) (Andreas Jurgeit)
Mission BioCapital (Lead Investor) (Steve Tregay)
Pfizer Venture Investments (Lead Investor)
Company Information
Schlieren, 8952
Switzerland
Management Team
Browse more venture capital transactions:
Prev: 9/17/2024: Nomad Solar Energy venture capital transaction
Next: 9/17/2024: Dunya Analytics venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs